Twist Bioscience Corporation (TWST) Debt Components
- 2022-09-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2022-06-30: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2022-03-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2021-09-30: Long-term Debt, Current MaturitiesUSD $1.55M; Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
Twist Bioscience Corporation Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Line of Credit Facility, Collateral Fees, Amount USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $1.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $100.00K | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | $833.00K | (m) | (m) | (m) | $833.00K | $4.00K |
| 2021-06-30 | $2.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $3.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $3.33M | $625.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $3.33M | $1.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $100.00K | (m) | (m) |
| 2020-09-30 | (m) | (m) | $4.17M | (m) | $3.33M | $833.00K | (m) | $4.17M | $85.00K |
| 2020-06-30 | $3.33M | $2.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $3.33M | $2.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $3.33M | $3.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $3.33M | $4.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $7.50M | $3.33M | $3.33M | $834.00K | (m) | $7.50M | $269.00K |
| 2019-06-30 | $3.33M | $5.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $3.33M | $5.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $3.33M | $6.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $2.50M | $7.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |